Avenue Therapeutics, Inc.
ATXI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $25,904 | $1,702 | $2,535 | $1,157,360 |
| - Cash | $2,594 | $1,783 | $6,708 | $3,763 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $23,310 | -$81 | -$4,173 | $1,153,597 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,696 | $4,052 | -$2,443 | $7 |
| % Margin | – | – | – | – |
| Net Income | -$11,652 | -$10,377 | -$3,552 | -$3,731 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.9 | -73.48 | -121.91 | -3.29 |
| % Growth | 98.8% | 39.7% | -3,605.5% | – |
| Operating Cash Flow | -$9,026 | -$9,451 | -$7,596 | -$3,750 |
| Capital Expenditures | $0 | -$3,000 | $0 | $0 |
| Free Cash Flow | -$9,026 | -$12,451 | -$7,596 | -$3,750 |